Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

4,016 public trials 394 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Completed

An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444.Study B

NCT01323660

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Jasper, Alabama, United States
  • GSK Investigational Site Torrance, California, United States
  • GSK Investigational Site Fort Collins, Colorado, United States
  • GSK Investigational Site Hartford, Connecticut, United States
View all 53 locations
View Trial Details
Completed

Study Evaluating the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT01323621

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Jasper, Alabama, United States
  • GSK Investigational Site Riverside, California, United States
  • GSK Investigational Site DeLand, Florida, United States
  • GSK Investigational Site Coeur d'Alene, Idaho, United States
View all 51 locations
View Trial Details
Completed

A Cross-Over Study to Evaluate Lung Function Response After Treatment With Umeclidinium (UMEC) 62.5 Micrograms (mcg), Vilanterol (VI) 25 mcg, and Umeclidinium/Vilanterol (UMEC/VI) 62.5/25 mcg Once-Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT02014480

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Humenné, Slovakia
  • GSK Investigational Site Kráľovský Chlmec, Slovakia
  • GSK Investigational Site Poprad, Slovakia
  • GSK Investigational Site Šaľa, Slovakia
View all 21 locations
View Trial Details
Completed

A Study to Compare the Impact of Fulticasone Furoate/Vilanterol vs. Tiotropium on Arterial Stiffness in COPD

NCT01395888

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
  • GSK Investigational Site Rosario, Santa Fe Province, Argentina
  • GSK Investigational Site Buenos Aires, Argentina
  • GSK Investigational Site Buenos Aires, Argentina
View all 55 locations
View Trial Details

Related conditions